Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Alexion Pharmaceuticals Inc gives FY 2014 outlook above analysts' estimates


Thursday, 30 Jan 2014 06:30am EST 

Alexion Pharmaceuticals Inc:Sees FY 2014 worldwide net product sales to be within a range of $2.00 to $2.02 bln.Sees FY 2014 Non-GAAP earnings per share (EPS) to be $3.70 to $3.80.FY 2014 revenue of $1.96 bln, EPS of $3.46 - Thomson Reuters I/B/E/S. 

Company Quote

161.56
0.03 +0.02%
18 Sep 2014